三个主要的SCFA减轻肺炎和组织重塑Nlrp3-依赖于小鼠的HDM诱导的中性喘
Barbara S S Tagé1, Michelangelo B Gonzatti2, Rodolfo P Vieira3,4,5
1Department of Science and Technology, Federal University of São Paulo (UNIFESP), São José dos Campos, SP, 12247-014, Brazil. barbara.tage@gmail.com.
Inflammation
|February 8, 2024
概括
短链脂肪酸 (SCFA) 可以减少肺炎和组织重塑中性友性喘模型. 炎症酶NLRP3在喘中起着重要作用.
科学领域:
- 免疫学 免疫学 免疫学
- 肺部病理学 肺部病理学
- 药理学 药理学是指药理学的学科.
背景情况:
- 中性喘的特点是持续的症状和肺中性粒细胞的升高.
- 短链脂肪酸 (SCFA) 显示出对过敏性喘的非药物治疗的潜力,但它们在中性友性喘中的有效性尚未得到证实.
- SCFA 影响免疫细胞反应和NLRP3 炎症酶,这是中性友性喘中潜在的治疗点.
研究的目的:
- 为了研究SCFA在减少肺炎和组织重塑中的有效性,在中性友性喘的小鼠模型中.
- 确定NLRP3炎症酶在中性友性喘中的作用及其对SCFA治疗的反应.
主要方法:
- 通过使用室内灰尘虫 (HDM) 暴露,诱导了中性友性喘的小鼠模型.
- 用SCFA (乙酸盐,酸盐或丁酸盐) 治疗小鼠,或用NLRP3淘汰 (KO) 评估NLRP3的贡献.
- 肺部炎症,细胞因子水平和组织重塑标记在支气管支气管洗液和肺组织中被分析.
主要成果:
- 高密度肌肉暴露显著增加了中性粒细胞的流入,炎症性细胞因子 (TNF-α,IFN-γ,IL-17A),原沉积和粘液分泌.
- 治疗SCFA有效地减少了肺炎和组织重塑.
- Nlrp3 缺乏特别影响组织重塑,包括原沉积,粘液分泌和TGF-β水平,但不影响一般炎症.
结论:
- 作为减轻中性友性喘的辅助疗法,SCFA显示出治疗潜力.
- NLRP3炎症酶是中性友性喘中组织重塑的关键调解者.
- 针对NLRP3可能有利于管理这种喘内型的气道改造.
更多相关视频
相关概念视频
01:26Asthma-II: Pathophysiology and Classification
2.7K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.7K
01:20Asthma: Pathogenesis and Management
398
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
398
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
298
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
298
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.8K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.8K
01:17Drugs Used in Lower Respiratory Disorders: Overview
442
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
442